Know Cancer

or
forgot password

Guilford Genomic Medicine Initiative (GGMI)


Phase 4
18 Years
N/A
Open (Enrolling by invite only)
Both
Breast Cancer, Ovarian Cancer, Colon Cancer, Thrombophilia

Thank you

Trial Information

Guilford Genomic Medicine Initiative (GGMI)


Inclusion Criteria:



- All patients scheduled for an upcoming well or new visit within the next 3 weeks with
their primary care physician (at the two implementation clinics).

Exclusion Criteria:

- Non-english speaking

- not consentable

- adopted

Type of Study:

Observational

Study Design:

Observational Model: Case-Crossover, Time Perspective: Prospective

Outcome Measure:

Evaluate effectiveness of family history collection and decision support for increasing appropriate referrals to genetic counselors for patients at risk of hereditary cancer syndromes

Outcome Description:

change in appropriate referal to genetic counseling one year before using MeTree compared to one year after.

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Geoffrey S Ginsburg, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Duke University

Authority:

United States: Institutional Review Board

Study ID:

W81XWH-05-1-0383

NCT ID:

NCT01372553

Start Date:

April 2005

Completion Date:

April 2012

Related Keywords:

  • Breast Cancer
  • Ovarian Cancer
  • Colon Cancer
  • Thrombophilia
  • Population invited are patient's at Primary care practices that come in for the well visits only
  • Breast Neoplasms
  • Colonic Neoplasms
  • Ovarian Neoplasms
  • Thrombophilia

Name

Location

Cone HealthGreensboro, North Carolina  27401